The abstract is read at the publisher; the summary is JClub's.
KRAS-LOH in pancreatic ductal adenocarcinoma is linked to metastatic dissemination and shorter overall survival, and only Kras-LOH tumor cells form tumors in immune-competent mice.
- Why it matters: The wild-type KRAS allele’s role during malignant progression is unclear, despite known associations between KRAS allelic imbalance and oncogene addiction.
- What they did: Using a first-in-class somatic mosaic lineage-tracing genetically engineered mouse model to follow Kras-LOH in vivo, the team combined cross-species autopsies/specimens with single-cell RNA sequencing and orthotopic isogenic transplants.
- The result: Kras-LOH parallels loss of tumor-cell interferon response, reduced CD8+ T cell infiltration, and immune evasion; restoring the wild-type allele abrogates tumorigenesis via activation of the TBK1-IRF axis in immunocompetent mice.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.